Literature DB >> 24593796

Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.

Timo S Spehl1, Sabine Hellwig2,3, Florian Amtage3, Cornelius Weiller3, Tobias Bormann3, Wolfgang A Weber1, Michael Hüll4, Philipp T Meyer1, Lars Frings4,5.   

Abstract

BACKGROUND: Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome with visuospatial deficits. PET studies have identified hypometabolism of the occipital cortex in PCA. There is, however, a huge overlap in clinical presentation and involvement of the occipital cortex between PCA, dementia with Lewy bodies (DLB), and Alzheimer's disease (AD). Syndrome-specific patterns of metabolism have not yet been demonstrated that allow for a reliable differentiation with [F-18]-FDG-PET.
METHODS: A total of 33 dementia patients (PCA n = 6, DLB n = 12, AD n = 15) who underwent [F-18]-FDG-PET imaging and a neuropsychological examination were retrospectively analyzed. Group comparisons of regional cerebral glucose metabolism were calculated with statistical parametric mapping. Extracted clusters were used to evaluate discrimination accuracy by logistic regression.
RESULTS: PCA patients showed a syndrome-specific area of hypometabolism in the right lateral temporooccipital cortex. DLB patients showed specific hypometabolism predominantly in the left occipital cortex. Logistic regression based on these two regions correctly separated patients with a sensitivity/specificity of 83/93% for PCA, 75/86% for DLB and 67/78% for AD. Overall accuracy was 73%.
CONCLUSION: [F-18]-FDG-PET could reveal syndrome-specific patterns of glucose metabolism in PCA and DLB. Accurate group discrimination in the differential diagnosis of dementia with visuospatial impairment is feasible.
Copyright © 2014 by the American Society of Neuroimaging.

Entities:  

Keywords:  Alzheimer's disease; Positron emission tomog-raphy; [F-18]-FDG-PET; dementia with Lewy bodies; posterior cortical atrophy

Mesh:

Substances:

Year:  2014        PMID: 24593796     DOI: 10.1111/jon.12104

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  13 in total

Review 1.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

2.  [Posterior cortical atrophy-a heterogeneous syndrome : A case series].

Authors:  Julian Conrad; Olympia Kremmyda; Tobias Högen; Matthias Brendel; Axel Rominger; Johannes Levin; Adrian Danek
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

Review 3.  Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.

Authors:  A Del Sole; S Malaspina; Alberto Magenta Biasina
Journal:  Funct Neurol       Date:  2016 Oct/Dec

Review 4.  Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-14       Impact factor: 5.081

5.  [Posterior cortical atrophy. Pathology, diagnosis and treatment of a rare form of dementia].

Authors:  M Ortner; A Kurz
Journal:  Nervenarzt       Date:  2015-07       Impact factor: 1.214

6.  18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Tarun D Singh; Daniel A Drubach; Matthew L Senjem; Anthony J Spychalla; Nirubol Tosakulwong; Val J Lowe; Keith A Josephs
Journal:  J Nucl Med       Date:  2016-09-29       Impact factor: 10.057

7.  Clinical and radiological profile of posterior cortical atrophy and comparison with a group of typical Alzheimer disease and amnestic mild cognitive impairment.

Authors:  Gautam Das; Souvik Dubey; Uma Sinharoy; Adreesh Mukherjee; Sourav Banerjee; Durjoy Lahiri; Atanu Biswas
Journal:  Acta Neurol Belg       Date:  2020-11-23       Impact factor: 2.396

8.  Clinical, FDG and amyloid PET imaging in posterior cortical atrophy.

Authors:  Tarun D Singh; Keith A Josephs; Mary M Machulda; Daniel A Drubach; Liana G Apostolova; Val J Lowe; Jennifer L Whitwell
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

9.  Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.

Authors:  Daniel Roquet; Marion Sourty; Anne Botzung; Jean-Paul Armspach; Frédéric Blanc
Journal:  Alzheimers Res Ther       Date:  2016-07-12       Impact factor: 6.982

10.  A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.

Authors:  Xiao-Dan Wang; Hui Lu; Zhihong Shi; Li Cai; Shuai Liu; Shuling Liu; Tong Han; Ying Wang; Yuying Zhou; Xinping Wang; Shuo Gao; Yong Ji
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.